Charcot-Marie-Tooth – Waisman Center – UW–Madison

Post-transcriptional microRNA repression of PMP22 dose in severe Charcot-Marie-Tooth disease type 1

Modulation of Schwann cell homeostasis by the BAP1 deubiquitinase

A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism. Human molecular genetics, ddac170

ACTL6a coordinates axonal caliber recognition and myelination in the peripheral nerve

MicroRNAs as Biomarkers of Charcot-Marie-Tooth Disease Type 1A

Revisiting the pathogenic mechanism of the GJB1 5′ UTR c.-103C > T mutation causing CMTX1

Genome-Edited Coincidence and PMP22-HiBiT Fusion Reporter Cell Lines Enable an Artifact-Suppressive Quantitative High-Throughput Screening Strategy for PMP22 Gene-Dosage Disorder Drug Discovery

Pmp22 super-enhancer deletion causes tomacula formation and conduction block in peripheral nerves

Transmembrane protease serine 5: a novel Schwann cell plasma marker for CMT1A.

Regulating PMP22 expression as a dosage sensitive neuropathy gene.